Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
Toluene,Inhalation TC,"2.3E+00
mg/m3","Study Type: epidemiological
(occupational)
Species: humans (printing shop workers)
Mode of Exposure: inhalation
Exposure Concentrations: high
exposure group (106 subjects) =
26 ppm (98 mg/m3); low exposure group
(86 subjects) = 3 ppm (11 mg/m3)
Duration: long duration (21 years)
and shorter duration (6 years)
Uncertainty Factors: 10 (3.16 for
pharmacokinetic variability and 3.16
for pharmacodynamics variability)","NOAEL = 26 ppm
(98 mg/m3)","NOAEL adjusted for
continuous exposure
(assuming 8 hours/day,
5 days/week to 24 hours/
day, 7 days/week)
NOAEL = 23 mg/m3
adj
TC = NOAEL /UF
adj","Neurotoxicity
(cognitive function:
attention, memory
and psychomotor
function)","CEPA: Group IV
unlikely to be
carcinogenic to
humans
(EC and HC, 1992b)
IARC: Group 3
not classifiable as to
its carcinogenicity
to humans
(IARC, 1999a)
US EPA IRIS:
inadequate
information to
assess carcinogenic
potential (US EPA,
2005c)","HC, 2011b
(based on
Seeber et al.,
2004, 2005)"
"Trichloroethylene
(TCE)",Oral TDI,"1.46E-03
mg/kg -day
BW","Study Type: subchronic (developmental)
Species: Sprague-Dawley rats
Mode of Administration: oral
(drinking water)
Exposure Regime: 0, 1.5, and
1100 ppm (equivalent to 0, 0.18, and
132 mg/kg -day); 3 dosing regimes:
BW
1) 3 months before pregnancy,
2) 2 months before and 21 days during
pregnancy, or 3) 21 days during
pregnancy only
Duration: variable (see Exposure
Regime above)
Uncertainty Factors: 100 (10 for
intraspecies variability and 10
for interspecies variability)","BMDL =
10
0.146 mg/kg -day
BW","BMD model
TDI = BMDL /UF
10","Developmental
toxicity
(fetal heart defects)","CEPA: Group II
probably
carcinogenic
to humans
(EC and HC, 1993g)
IARC: Group 1
carcinogenic
to humans
(IARC, 2014)
US EPA IRIS:
carcinogenic
to humans
(US EPA, 2011b)","HC, 2005
(based on
Dawson et al.,
1993)"
